Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer-assisted rational design of immunosuppressive compounds

G Grassy1, B Calas, A Yasri

  • 1Centre de Biochimie Structurale, UMR CNRS 9955, INSERM U414, Faculté de Pharmacie, Montpellier, France.

Nature Biotechnology
|August 14, 1998
PubMed
Summary

Researchers rationally designed potent immunosuppressive peptides using computational methods. These novel peptides, derived from HLA class I, show promise in modulating immune responses and enhancing allograft survival in mice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances in drug design of epidermal growth factor receptor inhibitors.

Current medicinal chemistry·2013
Same author

Lower fluid and fruits/vegetable intake in questionable dementia among older Hong Kong Chinese.

The journal of nutrition, health & aging·2010
Same author

White matter development in adolescence: a DTI study.

Cerebral cortex (New York, N.Y. : 1991)·2010
Same author

Estimation of stature by measuring fibula and ulna bone length in 2443 older adults.

The journal of nutrition, health & aging·2009
Same author

Can continuous pump feeding reduce the incidence of pneumonia in nasogastric tube-fed patients? A randomized controlled trial.

Clinical nutrition (Edinburgh, Scotland)·2009
Same author

Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Area of Science:

  • Immunology
  • Computational Chemistry
  • Drug Discovery

Background:

  • Developing immunosuppressive drugs is crucial for transplantation and autoimmune diseases.
  • Current methods often rely on understanding specific receptor interactions or mechanisms of action.
  • There is a need for novel strategies to design effective immunosuppressive agents.

Purpose of the Study:

  • To rationally design novel immunosuppressive peptides.
  • To enhance peptide potency without prior knowledge of receptor targets or action mechanisms.
  • To identify potential drug candidates for modulating immune responses.

Main Methods:

  • Utilized topological and shape descriptors for peptide design.
  • Employed molecular dynamics (MD) trajectories analysis to identify drug candidates.

Related Experiment Videos

  • Applied the strategy to develop peptides derived from the heavy chain of Human Leukocyte Antigen (HLA) class I.
  • Tested lead compounds in vitro and in vivo using a heterotopic mouse heart allograft model.

    • Main Results:

    • Successfully designed immunosuppressive peptides with enhanced potency.
    • Identified lead compounds derived from HLA class I, specifically a peptide from HLA-B2702 (amino acids 75-84).
    • Demonstrated that the designed peptide prolonged skin and heart allograft survival in mice.
    • The most potent rationally designed molecule showed approximately 100-fold higher immunosuppressive activity compared to the initial lead compound.

    Conclusions:

    • Rational design using computational descriptors and MD is effective for creating potent immunosuppressive peptides.
    • Peptides derived from HLA class I can be successfully engineered for therapeutic applications in transplantation.
    • The developed strategy offers a promising avenue for discovering novel immunosuppressive drug candidates.